Presentations -
-
Euation of the potential of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CD82 monoclonal antibody in a murine xenograft model
SNMMI2024 Annual Meeting 2024.6
-
Current Status and Future Prospects of Preclinical Development of Targeted Alpha Particle Therapy using 211At at Fukushima Medical University
International Conference on Interdisciplinary Life Sciences 2023 (ILS 2023) 2024.1
-
Possibility of 123I-meta-iodobenzylguanidine (MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal and pheocheomocytoma xenograft mice
SNMMI2023 Annual Meeting 2023.6
-
日本のアスタチン‐211を用いた標的α線治療開発の現状と福島県立医科大学の取組
笹川医学奨学金進修生同学会日本支部2022年度総会・学術セミナー 2023.3
-
Current Status and Future Prospects of Preclinical Development of Targeted Alpha Particle Therapy using 211At at Fukushima Medical University
2023.1
-
Similarities and differences of dosimetry between meta-[211At]astatobenzylguanidine (211At-MABG) and meta-[123I]iodobenzylguanidine (123I-MIBG) as companion diagnostic drug in PC12 pheochromocytoma model mice
EANM'22 - Annual Congress of the European Association of Nuclear Medicine 2022.10
-
低免疫原性ストレプトアビジン変異体と改変ビオチンを用いるプレターゲティングシステムの開発
日本放射線化学会第66回討論会（2022） 2022.9
-
悪性褐色細胞腫PC12移植マウスにおける123I-MIBGイメージングとex-vivo体内動態及び線量評価の比較
第62回日本核医学会学術総会 2022.9
-
Imaging of 5-HT2A receptors in rats with semi-chronic administration of phencyclidine
NEURO 2022 2022.7
-
Effects of single and repeated 211At-MABG treatments on tumor growth suppression in a pheochromocytoma xenograft
SNMMI2022 Annual Meeting 2022.6
-
Synthesis and evaluation of 211At-labeled bis-iminobiotin for pretargeted alpha radioimmunotherapy
SNMMI2022 Annual Meeting 2022.6
-
急性骨髄性白血病における211At標識抗CD82抗体の治療効果
第３回放射線災害・医科学研究拠点ワークショップ 2022.2
-
急性骨髄性白血病における211At標識抗CD82抗体の治療効果
第61回日本核医学会学術総会 2021.11
-
悪性褐⾊細胞腫PC12移植マウスにおける123I-MIBGと211At-MABGの体内動態及び線量評価
第61回日本核医学会学術総会 2021.11
-
Correlation of radiotoxicity and dosimetry of 211At-MABG in normal mice.
第61回日本核医学会学術総会 2021.11
-
高齢マウスの局所脳糖代謝に対する人参栄養湯の効果：インシュリン負荷による18F-FDG オートラジオグラフィーの画像手法を用いた評価
第61回日本核医学会学術総会 2021.11
-
第1相試験に向けた２１１Ａｔ－ＭＡＢＧの⾮臨床開発戦略
第61回日本核医学会学術総会 2021.11
-
正常マウスにおけるフリー 211Atの臓器毒性評価
第61回日本核医学会学術総会 2021.11
-
褐色細胞腫モデルにおける211At-MABGの反復投与による腫瘍成長の抑制効果の評価
第61回日本核医学会学術総会 2021.11
-
ヒト急性白血病モデルマウスにおける211At-CD33の体内動態
第61回日本核医学会学術総会 2021.11
-
ヒト急性白血病モデルマウスにおける211At-CD82の体内動態
第61回日本核医学会学術総会 2021.11
-
Evaluation of acute radiotoxicity profile of alpha-particle-emitting meta-211At-astato-benzylguanidine (211At-MABG) in normal BALB/c mice
SNMMI2021 Annual Meeting 2021.6
-
Evaluation of effect of Ninjin'yoeito on regional brain glucose metabolism by 18F-FDG autoradiography with insulin loading in superaged mice
SNMMI2021 Annual Meeting 2021.6
-
Effect of the targeted alpha therapy using mutant streptavidin bisiminobiotin pre-targeting system in a human gastric cancer cell xenograft
-
Synthesis of bis-iminobiotin derivatives and labeling with Astatine-211
-
Biodistribution studies of 211At labeled bis-iminobiotins for pretargeting radionuclide therapy
-
Optimization for pre-targeted radionuclide therapy using 211At labeled bis-iminobiotin
-
Similarities and differences of dosimetry between meta-[211At]astatobenzylguanidine (211At-MABG) and meta-[123I]iodobenzylguanidine (123I-MIBG) as companion diagnostic drug
-
Acute dose response of hemato-toxicity of 211At-MABG in normal mice
-
Effects and safety of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) comparison with 131I-meta-iodobenzylguanidine (131I-MIBG) in a pheochromocytoma mouse model
-
Preclinical Evaluation of Radiotoxicity of 211At-MABG in normal mice.
-
Biodistribution and dosimetry studies for the optimization of pre-targeted radionuclide therapy using 211At-labeled modified biotin.
EANM'20 - Annual Congress of the European Association of Nuclear Medicine
-
Evaluation of therapeutic effect of the targeted alpha therapy using Cupid-211At-labeled Psyche-B pretargeting system in a human gastric cancer cell xenograft.
EANM'20 - Annual Congress of the European Association of Nuclear Medicine
-
Search for the optimal bis-iminobiotin for the pretargeting strategy using a mutated low immunogenic streptavidin.
EANM'20 - Annual Congress of the European Association of Nuclear Medicine
-
Comparative evaluation of radiation dosimetry between meta-[211At]astatobenzylguanidine (211At-MABG) and meta-[123I]iodobenzylguanidine (123I-MIBG)
-
α放射体211At標識イミノビオチンの作成と安定性評価
日本放射線影響学会第63回大会
-
Differences and similarities in biodistribution, pharmacokinetics and metabolites of 211At-MABG versus 123I-MIBG in normal mice.
Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
-
Effects and safety of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared with 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model.
Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
-
Feasibility of cancer stem cells-targeted radioimmunotherapy for acute myelogenous leukemia with 211At-CXCR4 monoclonal antibody.
-
Development of a low immunogenic mutated streptavidin pretargeting strategy with 211At labeled modified biotin for advanced cancer treatment.
Society of Nuclear Medicine Annual Meeting (SNMMI 2020)
-
Effects of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) compared to 131I-meta-iodobenzylguanidine (131I-MIBG) on tumor growth suppression in a pheochromocytoma mouse model.
The Endocrine Society's 102nd Annual Meeting (ENDO2020)
-
Delta-like 1 homolog (DLK-1)を標的した治療開発および臨床的意義の検討
第60回日本肺癌学会学術集会
-
Delta-like 1 homolog (DLK-1)を標的した治療開発および臨床的意義
第32回日本バイオセラピィ学会学術集会総会
-
Search for TLC procedure of meta-[211At]astatobenzylguanidine ([211At]MABG)
-
211At-MABG dosimetry using 123I-MIBG as companion diagnostic drug in normal mice
-
Preliminary evaluation on pharmacokinetics and metabolites of 211At-MABG in normal mice
-
An effort to diagnostic and therapeutic nuclear medicine at Fukushima Medical University using two medical cyclotrons
-
An effort to diagnostic and therapeutic nuclear medicine at Fukushima Medical University using two medical cyclotrons.
International Symposium on Traends in Radiopharmaceuticals (ISTR 2019)
-
Delta-like 1 homolog (DLK1) expression in non-small-cell lung cancer and the development of radioimmunotherapy targeting DLK1
World Coference on Lung Cancer (WCLC 2019)
-
Evaluation of the potential of organ glucose metabolism by 18F-FDG accumulation with insulin loading in older mice compared with younger normal mice
The 66th Society of Nuclear Medicine Annual Meeting (SNMMI 2019)
-
Possibility of 123I-meta-iodobenzylguanidine (123I-MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG)
The 66th Society of Nuclear Medicine Annual Meeting (SNMMI 2019)
-
Synthesis of [211At]MABG Using Remote-controlled Synthesizer and Quality Evaluation
The ISRS 2019
-
Biodistribution and dosimetry of Free and meta-[211At]astatobenzylguanidine (MABG) in normal mice
The 11th International Symposium on TargetedAlpha-Therapy (TAT11)
-
Manufacture of [211At]MABG Using Remote-controllable Synthesizer and Quality Evaluation
-
Evaluation of the distribution of At-211 solution dispersion in the small an imal cage
-
Dosimetry of free 211At and meta-[211At]astatobenzylguanidine (MABG) in normal mice
-
Manufacture and Quality Evaluation Using Synthesizer of [211At]MABG
-
Is it possible to detect the contamination of At-211 using survey meter ?
-
Investigation of the influence of intratumoral glutathione status on the distribution of a hypoxic probe [18F]FMISO
WFNMB 2018
-
Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO
The 64rd Society of Nuclear Medicine Annual Meeting (SNMMI 2017)
-
Effect of eribulin on remodeling of tumor vasculature confirmed by FMISO PET imaging-Small-animal PET study in human breast cancer cell xenograft
The 64rd Society of Nuclear Medicine Annual Meeting (SNMMI 2017)
-
The Production of 211At at Fukushima Medical University
The 10th International Symposium on Targeted Alpha Therapy (TAT-10) in Kanazawa
-
Production of At-211 by In-house Cyclotron and Characterization at Fukushima Medical University
The 76th Annual Meeting of the Japan Radiological Society
-
Inflammatory Changes in Brain and Lymphoid Organs after Ischemic Stroke: PET Imaging for Cell Therapy
the International Stroke Conference 201T
-
Current Status and Future Prospects of Molecular Imaging and Targeted Radionuclide Therapy in Fukushima Medical University
Asian Forum for Accelerators and Detectors (AFAD 2017)
-
Current Status and Future Prospects of Molecular Imaging and Targeted Radionuclide Therapy in Fukushima Medical University
Asian Forum for Accelerators and Detectors (AFAD 2017)
-
FMISO PETイメージングによるeribulinの低酸素解除作用の実証：小動物PETと乳癌モデルを用いた検討
第５６回日本核医学学術総会
-
FMISO PETイメージングによるeribulinの腫瘍内低酸素状態解除作用の評価
第31回福島県核医学研究会
-
FMISO PETイメージングによるeribulinの腫瘍内低酸素状態解除作用の実証―小動物用PETと乳癌モデルを用いた検討―
第12回小動物インビボイメージング研究会
-
Effects of eribulin on remodeling of tumor vasculature evaluated with FMISO hypoxia imaging in a human breast cancer cell xenograft
The 63rd Society of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
Does FMISO-PET really visualize only hypoxic states?; accumulation mechanism assessment of FMISO in hypoxic cells in combination with mass spectrometry
The 63rd Society of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
Metabolic Aspects of [14C]Acetete in Rabbit Atherosclerotic Arteries at Different Feeding Conditions: In Vitro Evaluation for Atherosclerosis Imaging with [11C]Acetate
The 63rdSociety of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
Effects of eribulin on remodeling of tumor vascular evaluated with FMISO hypoxia imaging in a human breast cancer cell xenograft
The 63rd Society of Nuclear Medicine Annual Meeting
-
Effects of eribulin on remodeling of tumor vasculature evaluated with FMISO hypoxia imaging in a human breast cancer cell xenograft
The 63rd Society of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
Effects of eribulin on remodeling of tumor vascular evaluated with FMISO hypoxia imaging in a human breast cancer cell xenograft
The 63rd Society of Nuclear Medicine Annual Meeting
-
Metabolic Aspects of [14C]Acetete in Rabbit Atherosclerotic Arteries at Different Feeding Conditions: In Vitro Evaluation for Atherosclerosis Imaging with [11C]Acetate
The 63rdSociety of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
Does FMISO-PET really visualize only hypoxic states?; accumulation mechanism assessment of FMISO in hypoxic cells in combination with mass spectrometry
The 63rd Society of Nuclear Medicine Annual Meeting (SNMMI 2016)
-
肺癌細胞移植モデルに対するマルチキナーゼ阻害剤sorafenib治療後の腫瘍増殖能変化のFLTによる評価
日本分子イメージング学会第１１回総会・学術集会
-
肺癌細胞移植モデルに対するマルチキナーゼ阻害剤sorafenib治療後の腫瘍増殖能変化のFLTによる評価
日本薬学会第136年会
-
北海道大学核医学分子影像研究的现状与展望
第5回JSPS中国同窓会・学術セミナー
-
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015
-
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015
-
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015
-
Dynamic PET evaluation of the increased FLT accumulation after sorafenib treatment in mice bearing a human renal cell carcinoma xenograft
The 2015 World Molecular Imaging Congress
-
骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
その他の会議
-
Preclinical evaluation of thymidine phosphorylase imaging probe, [123I]IIMU, A road to First-in-human clinical study
Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry (JCSRC 2015)
-
イメージング質量分析法(IMS)による低酸素イメージング剤”FMISO”の腫瘍内代謝・集積機序の経時的評価
第５５回日本核医学会学術総会
-
14C-酢酸の家兎動脈硬化病変への集積機序：11C-酢酸による動脈硬化イメージングのための基礎的検討。
第５５回日本核医学会学術総会
-
Eribulinの低酸素解除作用のFMISO低酸素イメージングを用いたヒト乳癌癌移植モデルにおける評価
第５５回日本核医学学術総会
-
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015
-
Study of accumulation mechanism of hypoxia imaging probe “FMISO" in tumors by imaging mass spectrometry: A possible involvement of low-molecular metabolites
The 2015 World Molecular Imaging Congress
-
Dynamic PET evaluation of the increased FLT accumulation after sorafenib treatment in mice bearing a human renal cell carcinoma xenograft
The 2015 World Molecular Imaging Congress
-
Expression level of fatty acid-binding protein 5 increased in pro-inflammatory macrophage with atherosclerotic lesion formation; evaluation as a potential biomarker for atherosclerosis imaging
The European Society of Cardiology (ESC) Congress 2015
-
Sphigomyelin synthase 2 deficiency enhances glucose clearance and tissue uptake in mice
The 14th International Conference on Bioactive Lipids in Cancer, Inflammation, and Related Diseases
-
Thymidine phosphorylase (TP) expression in normal mice: comparison with biodistribution of a novel TP imaging probe
The 62nd Society of Nuclear Medicine Annual Meeting
-
Accumulation mechanism of non-targeted immunoglobulin G in atherosclerotic legions
The 62nd Society of Nuclear Medicine Annual Meeting
-
[111In-DTPA-D-Phe-1-Asp0-D-Phe1]-オクトレオチドの体内動態評価 : 放射能の腎集積性低減と腫瘍集積性の向上
日本薬学会第135回年会
-
イメージング質量分析（IMS）による低酸素イメージング剤“FMISO”の腫瘍内集積機序の検討：低分子代謝物の関与の可能性
日本分子イメージング学会第１０回総会・学術集会
-
Dynamic 18F-FLT PETを用いた腎癌細胞移植モデルにおけるsorafenib治療後のFLT集積亢進過程の評価
日本分子イメージング学会第１０回総会・学術集会
-
動脈硬化病変への免疫グロブリンＧ集積機序の探索：動脈硬化診断用薬剤開発へ応用に関する基礎的検討
第10回日本分子イメージング学会総会・学術総会
-
125I-BMIPPの肝臓への集積機序：食餌誘導性肥満マウスにおける検討
その他の会議
-
Hypoxia imaging with 18F-fluoromisonidazole for differentiating tumors from granulomas: a comparison with 18F-/14C-FDG in experimental rat models.
-
Effects of feeding conditions on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice.
-
Changes in tumor oxygen states after sorafenib therapy evaluated by using 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft.
-
Evaluation of dynamic changes in tumor hypoxia and proliferation after radiotherapy in human head and neck cancer xenograft using dual tracers of FMISO and FLT.
-
Mechanisms of anti-tumor effects underlying sorafenib treatment: evaluation of tumor oxygen states using 18F-FMISO in a human lung cancer xenograft.
-
Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.
-
Irbesartan reduces atherosclerosis in Watanabe Heritable Hyperlipidemic (WHHL) rabbits: Non-invasive imaging of inflammation with 18F-FDG PET
-
Effects of feeding conditions on the hepatic pharmacokinetics of radioiodine-labeled BMIPP in mice: Comparison with palmitic acid.
-
核医学教育講演8「小動物イメージング‐様々なモダリティーの特徴と注意点～なぜ小動物イメージングが必要～」
その他の会議
-
Dose-dependent elevation of 18F-FDG concentration in the blood after ARB administration: Experiment in mice given telmisartan.
-
頭頸部癌における放射線照射後の腫瘍増殖反応と腫瘍内低酸素状態の経時的変化：FLTとFMISOによる評価
その他の会議
-
FMISO PET reflects antiangiogenic tumor response after sorafenib treatment in human renal cell carcinoma xenograft.
-
腎細胞癌モデルにおける18F-FMISOによる腫瘍内酸素状態の評価。
その他の会議
-
Sequential evaluation of intratumoral proliferative activity after radiotherapy by FLT in human head and neck cancer xenograft.
-
[125I]BMIPPのマウス心筋への取り込みにおよぼす摂餌状態の影響。
その他の会議
-
Radioiodinated BMIPP as a potential probe for hepatic fatty acid metabolism: evaluation in mice at different feeding status.
-
Hypoxia imaging with 18F-fluoromisonidazole for differentiating tumors from granulomas: a comparison with 18F-/14C-FDG in experimental rat models.
その他の会議
-
Monitoring tumor proliferative activity after radiotherapy by FLT in head and neck cancer xenograft comparison with Ki67.
-
Effects of feeding conditions on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice.
その他の会議
-
Increased intratumoral FLT uptake after multi-kinase inhibitor sorafenib treatment in human renal cell carcinoma xenograft.
-
Changes in tumor oxygen states after sorafenib therapy evaluated by using 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft.
その他の会議
-
Monitoring intratumoral proliferative and hypoxic responses to radiotherapy by FLT and FMISO in human head and neck cancer xenograft.
-
動脈硬化血管とマクロファージの代謝解析：低酸素による解糖系・ペントースリン酸回路の代謝産物の増加。
その他の会議
-
FLT can early reflect response of tumor proliferation to multikinase inhibitor (sorafenib) treatment in a human renal cell carcinoma xenograft: comparison with Ki-67.
-
Evaluation of dynamic changes in tumor hypoxia and proliferation after radiotherapy in human head and neck cancer xenograft using dual tracers of FMISO and FLT.
その他の会議
-
骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―<sup>123</sup>I‐iomazenil SPECTによる検討
-
Mechanisms of anti-tumor effects underlying sorafenib treatment: evaluation of tumor oxygen states using 18F-FMISO in a human lung cancer xenograft.
その他の会議
-
腎細胞癌移植マウスにおけるマルチキナーゼ阻害剤Sorafenib治療後のFLTによる治療反応評価
-
肉芽腫・腫瘍の鑑別診断における18F-FMISO低酸素イメージング：小動物用PETを用いたラットモデルにおける14C-FDGとの比較。
その他の会議
-
がんの診断・治療効果評価におけるPETの応用~基礎研究を中心に~
-
Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.
その他の会議
-
腫瘍・肉芽腫における<sup>18</sup>F‐FMISO集積の特徴:<sup>18</sup>F‐FDG及び組織学的比較
-
Irbesartan reduces atherosclerosis in Watanabe Heritable Hyperlipidemic (WHHL) rabbits: Non-invasive imaging of inflammation with 18F-FDG PET
その他の会議
-
腎細胞癌移植モデルにおける抗血管新生剤（sorafenib）の治療反応のFMISO PETによる評価
その他の会議
-
放射線照射により生成される一酸化窒素は固形腫瘍の再酸素化に必須である.
-
抗血管新生剤(sorafenib)の抗腫瘍効果の機序：肺癌細胞移植モデルにおけるFMISOによる腫瘍内酸素状態の評価
その他の会議
-
動脈血栓能を反映する18F‐フルオロデオキシグルコースの血管集積
-
Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT
-
動脈硬化病変における炎症細胞への18F-FDG集積と低酸素との関連： バルーン傷害モデルでの検討
その他の会議
-
固形腫瘍内における放射線誘導性再酸素化の動態の評価
-
放射線照射により生成される一酸化窒素は固形腫瘍の再酸素化に必須である。
その他の会議
-
動脈血栓能を反映する18F‐フルオロデオキシグルコースの血管集積
その他の会議
-
18F-FLT can detect early antiproliferative response to anti-EGFR molecular targeting therapy (cetuximab) in human lung cancer xenograft.
-
腫瘍と肉芽腫の鑑別診断におけるDynamic 18F-Fluoro-L-a-methyltyrosine (18F-FAMT)-PETの有用性
その他の会議
-
FMISO PET reflects antiangiogenic tumor response to multi-kinase inhibitor (sorafenib) in human renal cell carcinoma xenograft.
-
FMISO PET reflects antiangiogenic tumor response to multi-kinase inhibitor (sorafenib) in human renal cell carcinoma xenograft.
その他の会議
-
18F-FLT but not 18F-FDG can early and dose-dependently detect antiproliferative responses of human tumor xenograft to epidermal growth factor receptor targeting with a tyrosine kinase inhibitor, gefitinib
-
Dose-dependent elevation of 18F-FDG concentration in the blood after ARB administration: Experiment in mice given telmisartan.
その他の会議
-
固形腫瘍内における放射線誘導性再酸素化の動態の評価
その他の会議
-
チミジンホスホリラーゼを標的とする新規腫瘍イメージング剤（123I-IIMU）の開発：マウス組織におけるチミジンホスホリラーゼ発現と123I-IIMU集積との関係。
その他の会議
-
Usefulness of [C-11]methionine in differentiating tumor from granuloma: Comparison with [F-18]FDG
-
18F-FMISOを用いた腎細胞癌移植モデルにおける抗血管新生療法（sorafenib）の早期治療反応の評価。
その他の会議
-
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: Molecular imaging with 14C-FDG and 99mTc-annexin A5.
-
18F-Fluorothymidine (18F-FLT) as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
-
18F-Fluorothymidine (18F-FLT) as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
その他の会議
-
Dynamic MET PET analysis has an additional value for differentiating tumors from granulomas: An experimental study using small animal PET
-
Omeprazole modifies physiologic FDG uptake in the GUT.
-
放射性ヨウ素標識BMIPPのマウス肝臓中挙動に及ぼす摂餌状態の影響：パルミチン酸との比較。
その他の会議
-
放射線照射後に生成される一酸化窒素は固形腫瘍の再酸素化に関与する
日本酸化ストレス学会学術集会プログラム・抄録集
-
FMISO PET can early evaluate antiangiogenic response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
その他の会議
-
Monitoring Early Response to Molecular-Targeting Therapy (Iressa) in Human tumor xenograft using 18F-FLT.
-
Biologic correlates of intratumoral heterogeneity in FDG distribution with regional expressions of glucose transporters and hexokinase-II in experimental tumors.
-
FMISO PET reflects antiangiogenic tumor response after sorafenib treatment in human renal cell carcinoma xenograft.
その他の会議
-
骨髄間質細胞移植は脳梗塞周囲の受容体機能を改善させる―<sup>123</sup>I‐iomazenil SPECTによる検討
再生医療
-
FMISO PET can early evaluate antiangiogenic response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
-
小動物用PET画像による腫瘍内18F-FDG集積の評価:オートラジオグラフィー画像との比較。
その他の会議
-
Dominant negative HIF-1a reduces FDG uptake in pancreatic cancer cells
-
Monitoring tumor proliferative activity after radiotherapy by FLT in head and neck cancer xenograft comparison with Ki67.
その他の会議
-
放射性標識核酸誘導体による腫瘍の核医学診断と内用療法。
その他の会議
-
18F-Fluorothymidine PET/CT as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
その他の会議
-
Effects of insulin and glucose loading on FDG uptake and GLUT expression in experimental inflammatory lesions and tumors
-
18F-Fluorothymidine PET/CT as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
-
動物用PETを用いた分子イメージング研究 ～腫瘍の診断と治療効果評価～。
その他の会議
-
Dynamics of 18F-FDG Uptake in Experimental Granuloma and Tumor: Basic Studies in Rat Models Using Small Animal PET/CT System
-
Effects of insulin and glucose loading on FDG uptake in experimental inflammatory lesions and malignant tumors
-
125I-BMIPP肝臓への集積機序：絶食及び非絶食マウスにおける検討。
その他の会議
-
高用量ARB投与によるFDG の組織集積の上昇：Telmisartan投与マウスでの検討。
その他の会議
-
Application of semiconductor gamma-camera for whole-body dynamic SPECT in small animal imaging.
-
Biologic Features of Intratumoral 18F-FMISO Distribution in a Rat Model of Glioma.
-
A novel radiolabeled probe for molecular imaging of thymidine phosphorylase: Suppressed accumulation into tumor cells by target gene knockdown.
-
肉芽腫・腫瘍における18F-FMISO-PETの有用性：小動物用PETを用いた基礎的検討。
その他の会議
-
18F-FLT can predict tumor proliferation response to radiotherapy in human head and neck cancer xenograft in comparison with Ki-67.
その他の会議
-
Early Evaluation of Antiangiogenic Response to Anti-EGFR Molecular Targeted therapy (cetuximab) by Using FMISO PET in Human Lung Cancer Xenograft.
-
チミジンホスホリラーゼを標的とする新規腫瘍イメージング剤の開発：siRNA導入による腫瘍細胞への集積低下。
その他の会議
-
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: Molecular imaging with 14C-FDG and 99mTc-annexin A5.
その他の会議
-
Evaluation of intratumoral 18F-FDG distribution using small animal PET: Comparison with autoradiography.
-
A novel radiolabeled probe for molecular imaging of thymidine phosphorylase: Suppressed accumulation into tumor cells by target gene knockdown.
その他の会議
-
腎細胞癌移植マウスにおけるマルチキナーゼ阻害剤Sorafenib治療後のFLTによる治療反応評価。
その他の会議
-
Evaluation of intratumoral 18F-FDG distribution using small animal PET: Comparison with autoradiography.
その他の会議
-
11C-Methionine but not 18F-FDG and 18F-FLT can differentiate tumor from granuloma in experimental rat models.
-
Sequential evaluation of intratumoral proliferative activity after radiotherapy by FLT in human head and neck cancer xenograft.
その他の会議
-
PREDICTION OF EARLY ANTIPROLIFERATIVE RESPONSE TO ANTI-EGFR MOLECULA-TARGETING THERAPY (CETUXIMAB) IN HUMAN TUMOR XENOGRAFT USING 18F-FLT PET.
-
分子イメージング装置を用いた研究とその成果～動物用PETを中心に～。
その他の会議
-
特別講演１．癌の診断・治療効果評価におけるPETの応用～基礎研究を中心に～
その他の会議
-
北海道大学における小動物インビボイメージング研究の現状。第7回小動物インビボイメージング研究会
その他の会議
-
PREDICTION OF EARLY ANTIPROLIFERATIVE RESPONSE TO ANTI-EGFR MOLECULA-TARGETING THERAPY (CETUXIMAB) IN HUMAN TUMOR XENOGRAFT USING 18F-FLT PET.
その他の会議
-
ApoE-/-マウス動脈硬化に対するテルミサルタンの治療効果： 99mTc-annexin A5による評価。
その他の会議
-
A radiolabeled uracil derivative as a novel SPECT tracer for thymidine phosphorylase (TP): cell specific uptake responses to TP expression.
-
A radiolabeled uracil derivative as a novel SPECT tracer for thymidine phosphorylase (TP): cell specific uptake responses to TP expression.
その他の会議
-
腫瘍・肉芽腫における18F-FMISO集積の特徴：18F-FDF及び組織学的比較。
その他の会議
-
Biological characteristics of intratumoral 18F-FMISO distribution in a rodent model of glioma.
その他の会議
-
Evaluation of early response to epidermal growth factor receptor targeting therapy with the tyrosine kinase inhibitor, gefitinib (Iressa) in human xenograft using 18F-FLT.
-
Utility of 99mTc-annexin A5 for Evaluating the Therapeutic Effect of ARB on Atherosclerosis: an Experimental Study with Telmisartan Treated apoE-/- Mice.
-
Biological characteristics of intratumoral 18F-FMISO distribution in a rodent model of glioma.
-
Hypoxia imaging with 18F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas: a comparison with FDG in experimental rat models using small animal PET.
その他の会議
-
Increased intratumoral FLT uptake after multi-kinase inhibitor sorafenib treatment in human renal cell carcinoma xenograft.
その他の会議
-
Early Evaluation of Antiangiogenic Response to Anti-EGFR Molecular Targeted therapy (cetuximab) by Using FMISO PET in Human Lung Cancer Xenograft.
その他の会議
-
FLT PET can early predict antiproliferative response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
その他の会議
-
Hypoxia imaging with 18F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas: a comparison with FDG in experimental rat models using small animal PET.
-
Biologic aspects of intratumoral [18F]FMISO distribution in a rodent model of glioma.
その他の会議
-
Dynamics of 18F-FDG uptake in experimental granulomas induced with activated macrophages: Comparison with malignant tumors
-
Monitoring intratumoral proliferative and hypoxic responses to radiotherapy by FLT and FMISO in human head and neck cancer xenograft.
その他の会議
-
Careful assessment of FDG uptake due to elevated FDG concentration in the blood and organs by high dose ARB administration: Experiment in mice given telmisartan.
その他の会議
-
Modification of FDG uptake by steroid pretreatment: a potential means for differentiating tumor from granuloma by PET
-
Effects of feeding conditions on the hepatic pharmacokinetics of radioiodine-labeled BMIPP in mice: Comparison with palmitic acid.
その他の会議
-
FLT PET can early predict antiproliferative response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
-
不安定プラークの検出における18F-FDGと99mＴｃ-annexin A5の有用性：ApoE-/-マウスの動脈硬化病変への集積と病理学的検討。
その他の会議
-
Radioiodinated BMIPP as a potential probe for hepatic fatty acid metabolism: evaluation in mice at different feeding status.
その他の会議
-
FLT can early reflect response of tumor proliferation to multikinase inhibitor (sorafenib) treatment in a human renal cell carcinoma xenograft: comparison with Ki-67.
その他の会議
-
ヒト癌移植マウスにおける抗EGFR抗体（Cetuximab）による分子標的療法：18F-FLT PETを用いた早期治療効果評価。
その他の会議
-
Utility of 99mTc-annexin A5 for Evaluating the Therapeutic Effect of ARB on Atherosclerosis: an Experimental Study with Telmisartan Treated apoE-/- Mice.
その他の会議
-
Biologic aspects of intratumoral [18F]FMISO distribution in a rodent model of glioma.
-
チミジンホスホリラーゼを標的とする新規腫瘍イメージング剤の開発：siRNAによる標的ノックダウンと腫瘍細胞への集積。
その他の会議
-
骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―<sup>123</sup>I‐iomazenil SPECTによる検討
その他の会議
-
Double-tracer autoradiographic study with histochemical interpretation for evaluating feasibility of 18F-FDG/99mTc-annexin A5 on vulnerable plaque detection.
その他の会議
-
Performance evaluation of a semiconductor spect system for small animal imaging.
-
Biologic Features of Intratumoral 18F-FMISO Distribution in a Rat Model of Glioma.
その他の会議
-
Careful assessment of FDG uptake due to elevated FDG concentration in the blood and organs by high dose ARB administration: Experiment in mice given telmisartan.
-
ヒト癌細胞移植マウスにおける抗EGFR抗体（cetuximab）による分子標的療法：FLTを用いた早期治療効果評価。
その他の会議
-
腎細胞癌移植マウスにおけるマルチキナーゼ阻害剤Sorafenib治療後のFLTによる治療反応評価
その他の会議
-
The therapeutic effect of telmisartan on atherosclerosis in apoE-/- mice: an evaluation with 99mTc-annexin A5.
-
Dynamic 11C-MET pet has an additional value for differentiating tumors from granulomas: an experimental study using small animal pet in comparison with 18F-FDG.
その他の会議
-
ヒト癌移植マウスにおける抗EGFR抗体（Cetuximab）による分子標的療法：18F-FMISOを用いた早期治療効果評価。
その他の会議
-
Dynamic 11C-MET pet has an additional value for differentiating tumors from granulomas: an experimental study using small animal pet in comparison with 18F-FDG.
-
ヒト癌移植マウスにおける抗VEGF抗体（Bevacizumab）による分子標的療法：FLTを用いた早期治療効果評価。
その他の会議
-
がんの診断・治療効果評価におけるPETの応用~基礎研究を中心に~
その他の会議
-
ヒト癌細胞移植マウスにおける抗EGFR抗体（Cetuximab）による分子標的療法：FLTを用いた早期治療効果評価。
その他の会議
-
Is MET valuable in differentiating cancer from granuloma?
-
放射線治療に対する腫瘍増殖反応の18F-FLTによる評価：ヒト頭頸部癌移植モデル動物におけるKi-67との比較検討。
その他の会議
-
Evaluation of FMISO uptake in rat tumor tissue:comparison with FDG uptake.
-
Evaluation of FMISO uptake in rat tumor tissue：comparison with FDG uptake.
その他の会議
-
腫瘍・肉芽腫における<sup>18</sup>F‐FMISO集積の特徴:<sup>18</sup>F‐FDG及び組織学的比較
その他の会議
-
The therapeutic effect of telmisartan on atherosclerosis in apoE-/- mice: an evaluation with 99mTc-annexin A5.
その他の会議
-
18F-Fluorothymidine (FLT) as tumor response predictor for anti-epidermal growth factor receptor (EGFR) antibody in human lung cancer xenograft.
その他の会議
-
18F-Fluorothymidine (FLT) as tumor response predictor for anti-epidermal growth factor receptor (EGFR) antibody in human lung cancer xenograft.
-
Dynamic MET PET analysis has an additional value for differentiating tumors from granulomas: An experimental study using small animal PET
その他の会議
-
Usefulness of 11C-methionine in evaluating cellular proliferation and differential diagnosis of tumor and granuloma
-
骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
その他の会議
-
Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT
その他の会議
-
The effect of steroid on FDG uptake in experimental tumor, granulomatous and inflammatory lesions
-
ラット腫瘍組織におけるFMISO集積の評価：FDG集積との比較。
その他の会議
-
18F-FLT can detect early antiproliferative response to anti-EGFR molecular targeting therapy (cetuximab) in human lung cancer xenograft.
その他の会議
-
Fluorothymidine (FLT)を用いた分子標的治療薬の治療効果予測。
その他の会議
-
シーメンス社製小動物用イメージング装置の使用経験。
その他の会議
-
Rhodococcus肉芽腫とラットglioma腫瘍ラットモデルにおけるFDG集積の比較検討。
その他の会議
-
Dynamics of 18F-FDG Uptake in Experimental Granuloma and Tumor: Basic Studies in Rat Models Using Small Animal PET/CT System
その他の会議
-
Dynamics of 18F-FDG uptake in experimental granulomas induced with activated macrophages: Comparison with malignant tumors
その他の会議
-
肉芽腫・腫瘍モデルラットにおけるFDGのダイナミクス：小動物用PETを用いた基礎的検討。
その他の会議
-
チミジンホスホリラーゼ標的SPECT薬剤の合成。
その他の会議
-
3H-FLTによる癌の分子標的療法の早期治療効果評価：担がんマウスにおける投与量依存性の検討。
その他の会議
-
細胞の増殖能評価、腫瘍－肉芽腫の鑑別診断における11C-methionineと18F-FDGの比較。
その他の会議
-
細胞の増殖能の評価及び腫瘍と肉芽腫の鑑別診断における11C-メチオニンの有用性：18F-FDGとの比較。
その他の会議
-
18F-FLT but not 18F-FDG can early and dose-dependently detect antiproliferative responses of human tumor xenograft to epidermal growth factor receptor targeting with a tyrosine kinase inhibitor, gefitinib
その他の会議
-
Usefulness of 11C-methionine in evaluating cellular proliferation and differential diagnosis of tumor and granuloma
その他の会議
-
11C-methionine(MET)の腫瘍・肉芽腫への集積性の違い：18F-FDG及び18F-FLTとの比較。
その他の会議
-
半導体検出器が装備された小視野PET装置の基礎的検討。
その他の会議
-
3H-FLTを用いた癌の分子標的療法（Iressa）の早期治療効果の評価。
その他の会議
-
Usefulness of [C-11]methionine in differentiating tumor from granuloma: Comparison with [F-18]FDG
その他の会議
-
Monitoring Early Response to Molecular-Targeting Therapy (Iressa) in Human tumor xenograft using 18F-FLT.
その他の会議
-
Application of semiconductor gamma-camera for whole-body dynamic SPECT in small animal imaging.
その他の会議
-
Evaluation of early response to epidermal growth factor receptor targeting therapy with the tyrosine kinase inhibitor, gefitinib (Iressa) in human xenograft using 18F-FLT
その他の会議
-
11C-Methionine but not 18F-FDG and 18F-FLT can differentiate tumor from granuloma in experimental rat models.
その他の会議
-
半導体検出器を用いた次世代PETカメラの開発-（３）空間分解能評価
その他の会議
-
腫瘍及び炎症組織における3H-FLTの集積。
その他の会議
-
Modification of FDG uptake by steroid pretreatment: a potential means for differentiating tumor from granuloma by PET
その他の会議
-
Performance evaluation of a semiconductor spect system for small animal imaging.
その他の会議
-
Is MET valuable in differentiating cancer from granuloma?
その他の会議
-
腫瘍と肉芽腫の鑑別診断におけるMETの有用性：ＦＤＧとの比較。
その他の会議
-
BCG肉芽腫及び悪性腫瘍への18F-ＦＤＧ集積に及ぼすステロイドの影響。
その他の会議
-
褐色脂肪のＦＤＧ集積に対する甲状腺機能の影響。
その他の会議
-
The effect of steroid on FDG uptake in experimental tumor, granulomatous and inflammatory lesions
その他の会議
-
Omeprazole modifies physiologic FDG uptake in the GUT.
その他の会議
-
腫瘍組織におけるＦＤＧ分布：Gluts及びHexokinase‐IIの発現との比較。
その他の会議
-
小動物SPECTにおける高エネルギー用ピンホールコリメータの試作。
その他の会議
-
Biologic correlates of intratumoral heterogeneity in FDG distribution with regional expressions of glucose transporters and hexokinase-II in experimental tumors
その他の会議
-
実験的腫瘍および炎症組織への１８F-FDG集積に及ぼすSteroidの影響。
その他の会議
-
Dominant negative HIF-1αの発現によるひと膵癌細胞のFDG集積低下。
その他の会議
-
Dominant negative HIF-1a reduces FDG uptake in pancreatic cancer cells
その他の会議
-
Effects of insulin and glucose loading on FDG uptake and GLUT expression in experimental inflammatory lesions and tumors
その他の会議
-
実験的腫瘍及び炎症組織におけるFDG集積とGLUT発現の関係：インシュリン·グルコース負荷の影響。
その他の会議
-
Effects of insulin and glucose loading on FDG uptake in experimental inflammatory lesions and malignant tumors
その他の会議
-
実験的腫瘍及び炎症組織へのFDG集積に及ぼすインシュリンとグルコース負荷の影響。
その他の会議
-
マンノース結合アルブミンの腫瘍集積。
その他の会議
-
新規イメージング技術を用いたα線放出核種の組織内局所線量評価の基礎検討
第58回アイソトープ・放射線研究発表会 2021.7
-
小動物SPECTにおける高エネルギー用ピンホールコリメータの試作。
その他の会議
-
腫瘍組織におけるＦＤＧ分布：Gluts及びHexokinase‐IIの発現との比較。
その他の会議
-
Effects of insulin and glucose loading on FDG uptake and GLUT expression in experimental inflammatory lesions and tumors
その他の会議
-
Dominant negative HIF-1a reduces FDG uptake in pancreatic cancer cells
その他の会議
-
実験的腫瘍および炎症組織への１８F-FDG集積に及ぼすSteroidの影響。
その他の会議
-
Dominant negative HIF-1αの発現によるひと膵癌細胞のFDG集積低下。
その他の会議
-
Effects of insulin and glucose loading on FDG uptake in experimental inflammatory lesions and malignant tumors
その他の会議
-
実験的腫瘍及び炎症組織におけるFDG集積とGLUT発現の関係：インシュリン·グルコース負荷の影響。
その他の会議
-
実験的腫瘍及び炎症組織へのFDG集積に及ぼすインシュリンとグルコース負荷の影響。
その他の会議
-
マンノース結合アルブミンの腫瘍集積。
その他の会議